Tag: NIVL

Societies seek consensus on NIVL management amid “paucity of rigorous data”

The diagnosis and management of non-thrombotic iliac vein lesions (NIVL) is the focus of a newly published set of consensus statements from the Vascular...

CX panel confronts conundrum of the moment: Should NIVL patients get...

Should non-thrombotic iliac vein lesion (NIVL) patients be given venous stents? That was the question raised to Gerry O’Sullivan (Galway, Ireland), a consultant interventional...

Primary patency after venous stenting best in NIVL patients, study finds

A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
stenting

Venous stenting: “We need to evaluate use, appropriateness and clinical indication”

An analysis of venous stent usage trends in the USA from 2014 to 2021 showed a “significant increase” in stents per day placed over...

New iliac vein stent offers “safe and effective” endovascular treatment option...

Based on the findings of a multicentre, randomised controlled trial, researchers have concluded that a new iliac vein stent—the Venastent (Tianhong)—provides a “safe and...

Rapid expansion in venous stenting brings migration, appropriate use and operator...

Venous stenting can have myriad benefits for carefully selected patients with deep and pelvic venous disease. However, as venous stenting has quickly gained popularity, concerns...

The new Venovo Venous Stent is changing clinical practice

Steven Dubenec (Sydney, Australia) and Gerard O’Sullivan (Galway, Ireland) discuss the impact of dedicated venous stents, in particular the Venovo venous stent (BD, formerly...